Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of Vitamin D Response in Tuberculosis
2010-023189-27Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of cholecalciferol in Tuberculosis (TB), sponsored by University of Birmingham. Primary endpoint: Interaction of GC genotype and baseline vitamin D level on post-supplementation vitamin D. Started Nov 2010; status: completed.
02
Drugs
cholecalciferol
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2010-023189-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023189-27.